Lupin is a USD 2.06 billion innovation led transnational pharmaceutical major producing and developing a wide range of branded and generic formulations as well as biotechnology products and APIs globally. The Company is a significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI, Anti-Infective and NSAID space and holds global leadership positions in the Anti-TB and Cephalosporin segment. Lupin is the 6th largest and fastest growing top 5 generics player in the US (5.3% market share by prescriptions, IMS Health) and the 3rd largest Indian pharmaceutical company by sales. The Company is also the fastest growing top 10 generic pharmaceutical players in Japan and South Africa (IMS). For the financial year ended March 2014, Lupin's Consolidated turnover and Profit after Tax were Rs. 120,600 million (USD 2.06 billion) and Rs. 18,364 million (USD 393 million) respectively.

Show more
Type
Public
HQ
Mumbai, IN
Founded
1968
Size (employees)
16,792 (est)
Website
lupin.com
Lupin was founded in 1968 and is headquartered in Mumbai, IN
Report incorrect company information

Lupin Office Locations

Lupin has offices in Mumbai, Baltimore and Zug
Mumbai, IN (HQ)
Laxmi Towers BKC Road
Mumbai, IN
Highway House Jawaharlal Nehru Rd
Zug, CH
1 Landis + Gyr-Strasse
Show all (4)
Report incorrect company information

Lupin News and Updates

Lupin Market 2018 Major Manufacturers Analysis And Industrial Applications Forecasts to 2022

WiseGuyReports.Com Publish a New Market Research Report On –“ Lupin Market 2018 Major Manufacturers Analysis And Industrial Applications Forecasts to 2022”. Posted via Industry Today. Follow us on Twitter @IndustryToday

UPDATE 1-India's Lupin posts surprise Q4 loss on one-time charge

May 15 (Reuters) - Lupin Ltd, India's second-largest drugmaker by revenue, reported a surprise quarterly loss on Tuesday due to a one-time charge related to the acquisition of U.S.-based Gavis Pharmaceuticals LLC.

Cephalexine Market Segments, Company Profiles, Landscape, Demand and Forecast to 2025

The Cephalexine market research report for the forecast period, 2018 to 2025 is an outcome of an extensive market study of the Cephalexine market and its performance across different regions. Detailed segmentation of both historic and future industries including prime categories adds value to the ov…

Cefaclor Market Analysis, Driving Factors by Manufacturers, Regions, Type, Application, Forecast 2025

The Cefaclor market research report for the forecast period, 2018 to 2025 is an outcome of an extensive market study of the Cefaclor market and its performance across different regions. Detailed segmentation of both historic and future industries including prime categories adds value to the overall …

Contraceptive Pills Industry Overview 2018 to 2022| Company Profile | Product Overview | Market Structure with Prominent Players Lupin Pharmaceuticals, Mankind Pharma, Teva pharmaceuticals, etc.

A Freshly Introduced Market Research Report, Contraceptive Pills Market Is Expected To Grow At The Rate Of About Around 2.2% Over The Forecast Period From 2018 To 2023. Key Markets Mentioned In This Research Report Include Asia-Pacific, Europe, And North America. Posted via Industry Today. Follow us…

Global Cephalosporin Market Scope, Share, Growth, Overview and Forecast to 2018

ReportsWeb.com published “Cephalosporin Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more
Report incorrect company information